Abstract: An electrical enclosure wherein an electrical component can be moved between various positions (e.g., connected, disconnected, test, etc.) without opening an enclosure door. The electrical enclosure supports a component for movement between a withdrawn position, a test position, and an inserted position. A handle is accessible by an operator from an exterior of the enclosure and is configured to move the component between the respective positions without having to open the enclosure. The handle is integral with the enclosure and thus an operator needs no special tool or other device to effect movement of the electrical component between its respective positions.

Abstract: The present disclosure is directed to a mobile machine, such as hydronic surface heater designed to be transported to a potentially remote worksite and operated for an extended period of time. The machine has a fueled component, such as a burner, fueled by a fuel supply system having at least two fuel tanks that are operably connected to one another by a connection line having an electronically controlled valve therein. The valve is coupled to the machine's electrical system, such as being coupled to the output of the machine's main breaker, so as to be opened whenever the machine is operating but to be otherwise closed. The fuel supply system thus has, in effect, a single tank when the machine is running and multiple separated tanks when the machine is not running. Fuel spill risks therefore are mitigated without having to sacrifice operating time and without significantly complicating the machine's fuel supply systems or its controls.

Abstract: An electronic circuit includes a microcontroller processor (410), a peripheral (420) coupled with the processor, an endian circuit (470) coupled with the processor and the peripheral to selectively provide different endianess modes of operation, and a detection circuit (140) to detect a failure to select a given endianess, whereby inadvertent switch of endianess due to faults is avoided. Other circuits, devices, systems, methods of operation and processes of manufacture are also disclosed.

Abstract: A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.

Abstract: An electrical enclosure wherein an electrical component can be moved between various positions (e.g., connected, disconnected, test, etc.) without opening an enclosure door. The electrical enclosure supports a component for movement between a withdrawn position, a test position, and an inserted position. A handle is accessible by an operator from an exterior of the enclosure and is configured to move the component between the respective positions without having to open the enclosure. The handle is integral with the enclosure and thus an operator needs no special tool or other device to effect movement of the electrical component between its respective positions.

Abstract: A power electronics device with an improved pre-charge circuit configuration is provided. More specifically, the input of the motor drive module may accept an AC or DC source voltage. In this way, the pre-charge circuit of the motor drive module may be utilized whether the motor drive is coupled to an AC or DC source.

Abstract: A power electronics device with an improved pre-charge circuit configuration is provided. More specifically, the input of the motor drive module may accept an AC or DC source voltage. In this way, the pre-charge circuit of the motor drive module may be utilized whether the motor drive is coupled to an AC or DC source.

Abstract: A method and system for triggering an implantable medical device for risk stratification measurements is disclosed. An implantable medical device having a hermetically sealed enclosure and memory disposed within the hermetically sealed enclosure. The device is programmed to record a physiological signal in response to at least one of a plurality of risk stratification measurement triggers. The stored signal is useful for implementing a variety of risk stratification for sudden cardiac death techniques.

Abstract: A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.

Abstract: A system, comprising a sterilizable package; an implantable medical device placed inside the sterilizable package; and an electrical interface electrically coupled to the implantable medical device and extending from inside the sterilizable package to outside the sterilizable package. In various embodiments, the interface may include package contacts electrically coupled to electrode terminals on the implantable medical device, patient terminals and conductors extending between the package contacts and the patient terminals.

Abstract: A system, comprising a sterilizable package; an implantable medical device placed inside the sterilizable package; and an electrical interface electrically coupled to the implantable medical device and extending from inside the sterilizable package to outside the sterilizable package. In various embodiments, the interface may include package contacts electrically coupled to electrode terminals on the implantable medical device, patient terminals and conductors extending between the package contacts and the patient terminals.

Abstract: A pacing control is used in a multiple-chamber cardiac pacing system, which, upon detecting an atrial arrhythmia, automatically switches to a special therapy mode and administers a selected anti-tachycardia pacing (ATP) therapy in the atrium, and which switches to a standard pacing mode following delivery of the ATP therapy. The pacing control adjusts the timing of pacing pulses to be delivered to the atrium and/or the ventricle to minimize any potential ventricular pauses that may result from the switch from the therapy mode to the standard pacing mode.

Abstract: A method of operating a cardiac pacing device that optimizes the mechanical heart rate using coordinated potentiation therapy while maximizing the opportunity for intrinsic AV conduction to occur. The method may include adjusting the timing of extra stimulus intervals during coupled or paired pacing to promote AV conduction and to effect changes in rate according to certain embodiments of the invention. Other embodiments may include adjusting the atrial pacing rate to achieve a desired target rate consistent with AV conduction. A mode switch to a dual-chamber pacing mode may be provided according to certain embodiments of the invention to ensure a ventricular rate that meets or exceeds a minimum mechanical rate.

Abstract: The invention provides systems to prevent the delivery of antitachycardia pacing (ATP) following a defibrillation threshold (DFT) induction at implant. An algorithm that classifies episodes as induced or spontaneous is implemented, thereby enabling the ATP during charging feature to be operable only when spontaneous episodes are detected while temporarily suspending the ATP feature during the delivery of defibrillation shock after induction has been confirmed. Further, a user interface enables users to interact with an implantable medical device (IMD), particularly for setting a defibrillation threshold (DFT) or a 50 Hz burst from a single programmer screen. The user interface includes various functionalities to promote quick user access to parameters that govern diagnosis, therapy and other features of the IMD. A single screen enables the user to complete automatic and/or manual DFT inductions or a 50 Hz burst from a programmer interface while acquiring associated documentation from the same interface.

Abstract: A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.

Abstract: A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.

Abstract: A system and method for delivering both anti-tachy pacing (ATP) therapy and high-voltage shock therapy in response to detection of abnormal cardiac rhythms is disclosed. The system controls the time between delivering ATP therapy and the charging of high-voltage capacitors in preparation for shock delivery based on a predetermined set of criteria. In one embodiment, the inventive system operates in an ATP During Capacitor Charging (ATP-DCC) mode wherein all, or substantially all, of the ATP therapy is delivered during charging of the high-voltage capacitors. Based on evaluation of the predetermined set of criteria, the system may switch to an additional ATP Before Capacitor Charging (ATP-BCC) mode, wherein substantially all of the ATP therapy is delivered prior to charging of the high-voltage capacitor. According to one aspect of the invention, the predetermined set of criteria is based, at least in part, on the effectiveness of previously-delivered ATP therapy.

Abstract: An apparatus assembles a heat exchanger core having first and second side plates. The first and second side plates cooperate with first and second end plates to sandwich a plurality of layered tubes and fin plates therebetween. The apparatus includes a lifting mechanism for stacking the tubes and fin plates with respect to one another to define a layered stack having opposite sides and opposite ends. A side plate assembling mechanism associates the first and second side plates on opposite sides of the layered stack. An end plate assembling mechanism associates the first and second end plates on opposite ends of the layered stack.

Abstract: An apparatus for aligning and delivering fins manufactured in a fin mill for use in manufacture and assembly of heat exchangers used for controlling temperature conditions. The apparatus includes first and second conveyors, the first conveyor receiving and transporting fins emanating from a fin mill, and the second conveyer delivering the fins to an apparatus for manufacturing and assembling a heat exchanger. A tier of chutes reorient the direction of the fins with respect to the direction of the conveyor travel.

Abstract: An apparatus for alignment and delivery of tubing for use in manufacture and assembly of heat exchangers used for controlling temperature conditions. The apparatus includes a drum into which bulk tubes are loaded. The drum aligns and deposits the tubes onto a conveyor which transports the tubes to a feed magazine. An alignment mechanism aligns the tubes within the feed magazine for use in the process of the assembly of the heat exchanger.